128739-92-4 Usage
Uses
Used in Organic Synthesis:
Trans-3-(boc-amino)-4-methoxypyrrolidine is used as a precursor in organic synthesis for the preparation of various pharmaceutical and bioactive compounds. The Boc-protected amino group allows for selective reactions and subsequent deprotection to yield the desired amine-containing products.
Used in Pharmaceutical Research:
In pharmaceutical research, trans-3-(boc-amino)-4-methoxypyrrolidine is utilized as a building block for the development of novel drug candidates. Its trans configuration and the presence of the methoxy group contribute to the compound's chiral properties and specific chemical and biological characteristics, making it suitable for the design and synthesis of chiral pharmaceuticals.
Used in Chiral Molecule Preparation:
Trans-3-(boc-amino)-4-methoxypyrrolidine is used as a chiral intermediate for the preparation of enantiomerically pure compounds. Its trans configuration facilitates the synthesis of chiral molecules with specific biological activities, which are essential in various pharmaceutical applications.
Used in Chemical and Pharmacological Studies:
trans-3-(boc-amino)-4-methoxypyrrolidine is also employed in chemical and pharmacological studies to explore its potential applications and properties. The methoxy group imparts specific chemical and biological properties to the compound, making it valuable for further research and development in the fields of chemistry and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 128739-92-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,7,3 and 9 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 128739-92:
(8*1)+(7*2)+(6*8)+(5*7)+(4*3)+(3*9)+(2*9)+(1*2)=164
164 % 10 = 4
So 128739-92-4 is a valid CAS Registry Number.
128739-92-4Relevant academic research and scientific papers
CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
-
Paragraph 00268, (2019/02/25)
The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.
Chemoenzymatic synthesis of (3S,4S)- and (3R,4R)-3-methoxy-4- methylaminopyrrolidine
Kamal, Ahmed,Shaik, Ahmad Ali,Sandbhor, Mahendra,Malik, M. Shaheer,Kaga, Harumi
, p. 8057 - 8059 (2007/10/03)
Facile chemoenzymatic enantioselective synthesis of (3S,4S)-3-methoxy-4- methylaminopyrrolidine, a key intermediate for a new quinolone antitumor compound AG-7352 has been described. This methodology illustrates the preparation of 3-azido-1-benzyloxycarbo
7-(1-PYRROLIDINYL)-3-QUINOLONE-AND-NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS AND FEED ADDITIVES
-
, (2008/06/13)
7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives, of the formula in which X1 is halogen, X2 is hydrogen, halogen, amino or other radical, R1 is alkyl, cycloalkyl, optionally substituted phenyl or other radical, R2 is hydrogen, alkyl or a dioxolylmethyl radical, R 3 i s A is N, CH, C-halogen, or the like, or forms a bridge with R1, and addition products thereof
